Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nordic Research Network is a Finland-based vaccine clinical research organization focused on conducting vaccine trials in adult volunteers. The entity appears to be the closest identifiable match to the requested name "Nordic Vaccine Research Network," but the official name used publicly is Nordic Research Network (NRN). The company was founded in 2007 by Professor Timo Vesikari and has conducted vaccine studies including avian influenza, herpes zoster, and hepatitis B vaccine programs, largely in association with Tampere University’s vaccine research infrastructure. Its work is centered on clinical evaluation of vaccine safety, immunogenicity, and efficacy rather than commercialization of an in-house therapeutic pipeline. NRN also highlights ongoing research interest in norovirus vaccines and intellectual property related to a combined rotavirus VP6 and norovirus virus-like particle vaccine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nordic Vaccine Research Network.